Vifor Pharma - Articles and news items

Vifor Pharma to top cardio-renal care after Galenica completes Relyapsa acquisition

Industry news / 6 September 2016 / Niamh Louise Marriott, Digital Content Producer

The combination of Galenica’s Vifor Pharma business with Relypsa will create a significant player in cardio-renal care in the US and further strength…

 

The deadline for submissions to the EPR Awards is 9 June 2017! Entry is FREE, so don't delay...
+